Last reviewed · How we verify
NCT04944433
Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients
trial in Coronavirus Disease 2019 Vaccines in 950 participants. Completed in 4 August 2022.
4 August 2022
Quick facts
| Lead sponsor | Hospital Italiano de Buenos Aires |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 950 |
| Start date | 9 April 2021 |
| Primary completion | 4 August 2022 |
| Estimated completion | 4 August 2022 |
| Sites | 1 location across Argentina |
Conditions studied
- Coronavirus Disease 2019 Vaccines — all drugs for Coronavirus Disease 2019 Vaccines →
- Renal Dialysis — all drugs for Renal Dialysis →
Sponsor
Hospital Italiano de Buenos Aires
Who can join
18 and older, any sex, with Coronavirus Disease 2019 Vaccines or Renal Dialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is unknown whether Coronavirus disease 2019 vaccines confer the same high level of protection in patients with kidney disease as reported for participants in recent trials, who were generally healthy. Objectives: To evaluate the safety and efficacy of Coronavirus disease 2019 vaccines in hemodialysis patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Safety and Effectiveness of COVID-19 SPUTNIK V Vaccine in Dialysis Patients
Rosa-Diez G, Papaginovic Leiva MM, Lombi F, Crucelegui MS, et al · · 2021 · cited 1× · DOI 10.1101/2021.10.21.21265349
Verify or expand the search:
- PubMed search for NCT04944433
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hospital Italiano de Buenos Aires trials
Trials by the same sponsor.
- NCT07397416 — Impact of Implementing a Rapid PCR-based Algorithm for Carbapenemase-producing Enterobacterales (CPE) and Infection Cont · NA · not yet recruiting
- NCT07167173 — Predictive Model for Multidrug Resistance in Patients Admitted to the Emergency Department With Sepsis · not yet recruiting
- NCT06683781 — Ventilatory Settings and Monitoring Variables Associated With Weaning Failure in Critically Ill Patients · recruiting
- NCT06573723 — Institutional Registry of Rare Diseases · recruiting
- NCT06609798 — Ultrasound Assessment During Weaning from Mechanical Ventilation · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04944433 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Italiano de Buenos Aires
- Last refreshed: 5 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04944433.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing